Clinical trials recruiting in Jeju City, South Korea

Phase breakdown

Conditions recruiting in Jeju City, South Korea

Recruiting trials in Jeju City, South Korea

• A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
  NCT05217810 · Phase: Not specified · Ages: 12 Years to 100 Years · Sex: All (male and female)
• A Study of Brenipatide in Adult Participants With Major Depressive Disorder
  NCT07412756 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
  NCT06246123 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICM
  NCT07347691 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female)
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
  NCT07181109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Jeju City, South Korea?

5 recruiting trials have at least one study site in Jeju City, South Korea.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.